BAYRY News and Press, Bayer AG ADR From 08/09/22

BeiGene ( NASDAQ: BGNE ) and Novartis' ( NYSE: NVS ) tislelizumab met the main goal of being as good as Bayer's ( OTCPK:BAYZF ) ( OTCPK:BAYRY ) Nexavar (sorafenib) in improving overall survival (OS) of patients with a type of liver cancer in a phase 3 trial...

This month I had a total of 11 transactions. I sold my positions in Power REIT and Reinsurance Group of America. I reached over €1,000 in forward dividends. In contrast to the first half a year of 2022, July was a good month when it comes to stock returns. July wa...

Hutchmed (China) ( NASDAQ: HCM ) said its medicine fruquintinib met the main goal of overall survival (OS) in patients with advanced, refractory metastatic colorectal cancer (CRC) in a phase 3 trial. The study called FRESCO-2 evaluated fruquintinib plus be...

The U.S. Food and Drug Administration approved the expanded use of Bayer's ( OTCPK:BAYRY ) ( OTCPK:BAYZF ) medicine Nubeqa, in combination with docetaxel, to treat patients with metastatic hormone-sensitive prostate cancer (mHSPC). Nubeqa (darolutamide) was alread...

In Q2 2022, Bayer delivered strong results across all of the company's divisions. Bayer generated revenues of EUR 12.8 billion (+9.6% year over year), and EBITDA before special items jumped by more than 30% to EUR 3.3 billion. Bayer also guided an improved FY 2022 outlook and high...

Bayer Aktiengesellschaft (BAYZF) Q2 2022 Results Conference Call August 04, 2022 09:00 AM ET Company Participants Oliver Maier - Head, IR Werner Baumann - CEO Wolfgang Nickl - CFO Rodrigo Santos - Head, Crop Science Stefan Oelrich - Head, Pharmaceuticals ...

The following slide deck was published by Bayer Aktiengesellschaft in conjunction with their 2022 Q2 earnings call. For further details see: Bayer Aktiengesellschaft 2022 Q2 - Results - Earnings Call Presentation

Bayer's ( OTCPK:BAYRY ) ( OTCPK:BAYZF ) Q2 sales grew on the back of Crop Science and Consumer Health businesses, while the company also raised its FY22 outlook. The German conglomerate's core EPS grew +19.9% Y/Y to €1.93. EBITDA before special items increase...

Bayer ( OTCPK:BAYRY ) ( OTCPK:BAYZF ) signed an agreement with Chevron ( NYSE: CVX ) to increase its ownership to a majority stake of 65% in winter oilseed producer CoverCress (CCI). The German conglomerate said the remaining 35% of CCI will continue to be ...

Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may be worth your time for further analy...